BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

  December 10, 2024

   · 

  3 min read
• Press Releases

  Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreated Multiple Myeloma

  December 10, 2024

   · 

  6 min read
• Press Releases

  Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024

  December 10, 2024

   · 

  6 min read
• Press Releases

  Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease

  December 10, 2024

   · 

  13 min read
• Press Releases

  CatalYm Highlights Visugromab’s Potential to Treat Cachexia in Cancer Patients at International SCWD Conference

  December 10, 2024

   · 

  4 min read
• Press Releases

  Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial

  December 10, 2024

   · 

  7 min read
• Press Releases

  OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219

  December 10, 2024

   · 

  11 min read
• Press Releases

  NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia

  December 10, 2024

   · 

  16 min read
• Press Releases

  Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development

  December 10, 2024

   · 

  5 min read
• Press Releases

  Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference

  December 10, 2024

   · 

  1 min read